Cheshire, UK--(Marketwire - July 22, 2008) - London, UK; Brentwood, TN, US: 22 July 2008 - Protherics PLC (the"Company”), the international biopharmaceutical company focused on critical care and cancer, is pleased to announce that Resolutions 1 to 7 and 9 to 11 put forward at the Annual General Meeting of the Company held earlier today were passed. Since Resolution 7 was passed, Resolution 8 was withdrawn.
